Effect of hachimijiogan against renal dysfunction and involvement of hypoxia-inducible factor-1 in the remnant kidney model

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Goto, Hirozo ^a   Oka, Hiroshi ^a   Koizumi, Keiichi ^a   Nakamura, Shin ^b   Tsuneyama, Koichi ^a   Zhou, Yue ^a   Jo, Michiko ^a   Fujimoto, Takako ^a   Sakurai, Hiroaki ^a   Shibahara, Naotoshi ^a   Saiki, Ikuo ^a   Shimada, Yutaka ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Biomedical Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN HEXETIL; GLUCOSE TRANSPORTER 1; HACHIMIJIOGAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY MASS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINE VOLUME;

EID: 79955087505     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2011/348686     Document Type: Article

References (36)

1. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization New England Journal of Medicine 2004 351 13 1296 1305
2. Lysaght M. J., Maintenance dialysis population dynamics: current trends and long-term implications Journal of the American Society of Nephrology 2001 13 supplement 1 S37 S40
3. Remuzzi G., Bertani T., Pathophysiology of progressive nephropathies New England Journal of Medicine 1998 339 20 1448 1456 (Pubitemid 28516069)
4. Fine L. G., Bandyopadhay D., Norman J. T., Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia Kidney International, Supplement 2000 57 75 S22 S26
5. Eckardt K. U., Rosenberger C., Jrgensen J. S., Wiesener M. S., Role of hypoxia in the pathogenesis of renal disease Blood Purification 2003 21 3 253 257 (Pubitemid 36649375)
6. Marx J., How cells endure low oxygen Science 2004 303 5663 1454 1456 (Pubitemid 38314393)
7. Ohtomo S., Nangaku M., Izuhara Y., Takizawa S., Strihou C. Y., Miyata T., Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model Nephrology Dialysis Transplantation 2008 23 4 1166 1172 (Pubitemid 351767476)
8. Masuda Y., Shimizu A., Mori T., Ishiwata T., Kitamura H., Ohashi R., Ishizaki M., Asano G., Sugisaki Y., Yamanaka N., Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis American Journal of Pathology 2001 159 2 599 608 (Pubitemid 32751090)
9. Terasawa K., Kampo: Japanese-Oriental Medicine, insights from clinical cases K.K. Standard McIntyre 1993 243 244
10. Nakagawa T., Yokozawa T., Yamabe N., Rhyn D. Y., Goto H., Shimada Y., Shibahara N., Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats Journal of Pharmacy and Pharmacology 2005 57 9 1205 1212 (Pubitemid 41391780)
11. Yamabe N., Yokozawa T., Kim H. Y., Cho E. J., Protective effect of Hachimi-jio-gan against renal failure in a subtotal nephrectomy rat model Journal of Pharmacy and Pharmacology 2005 57 12 1637 1644 (Pubitemid 41752278)
12. Manotham K., Tanaka T., Matsumoto M., Ohse T., Miyata T., Inagi R., Kurokawa K., Fujita T., Nangaku M., Evidence of tubular hypoxia in the early phase in the remnant kidney model Journal of the American Society of Nephrology 2004 15 5 1277 1288 (Pubitemid 38526009)
13. Tanaka T., Kojima I., Ohse T., Ingelfinger J. R., Adler S., Fujita T., Nangaku M., Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model Laboratory Investigation 2005 85 10 1292 1307 (Pubitemid 41348643)
14. Kumada T., Tsuneyama K., Hatta H., Ishizawa S., Takano Y., Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital Modern Pathology 2004 17 9 1141 1149 (Pubitemid 39128241)
15. Nangaku M., Eckardt K. U., Hypoxia and the HIF system in kidney disease Journal of Molecular Medicine 2007 85 12 1325 1330 (Pubitemid 50004091)
16. Wenger R. H., Stiehl D. P., Camenisch G., Integration of oxygen signaling at the consensus HRE Science's STKE 2005 2005 306 re12
17. Katavetin P., Miyata T., Inagi R., Tanaka T., Sassa R., Ingelfinger J. R., Fujita T., Nangaku M., High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway Journal of the American Society of Nephrology 2006 17 5 1405 1413 (Pubitemid 43673421)
18. Katavetin P., Inagi R., Miyata T., Tanaka T., Sassa R., Ingelfinger J. R., Fujita T., Nangaku M., Albumin suppresses vascular endothelial growth factor via alteration of hypoxia-inducible factor/hypoxia-responsive element pathway Biochemical and Biophysical Research Communications 2008 367 2 305 310
19. Hostetter T. H., Olson J. L., Rennke H. G., Venkatachalam M. A., Brenner B. M., Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation Journal of the American Society of Nephrology 2001 12 6 1315 1325 (Pubitemid 32472647)
20. Song Y. R., You S. J., Lee Y. M., Chin H. J., Chae D. W., Oh Y. K., Joo K. W., Han J. S., Na K. Y., Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney Nephrology Dialysis Transplantation 2010 25 1 77 85
21. Hirawa N., Uehara Y., Kawabata Y., Numabe A., Takada S., Nagoshi H., Gomi T., Ikeda T., Omata M., Hachimi-jio-gan extract protects the kidney from hypertensive injury in dahl salt-sensitive rat American Journal of Chinese Medicine 1996 24 3-4 241 254 (Pubitemid 126764449)
22. Yokozawa T., Yamabe N., Cho E. J., Nakagawa T., Oowada S., A study on the effects to diabetic nephropathy of hachimi-jio-gan in rats Nephron Experimental Nephrology 2004 97 2 e38 e48
23. Yamabe N., Kang K. S., Goto E., Tanaka T., Yokozawa T., Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats Biological and Pharmaceutical Bulletin 2007 30 3 520 526 (Pubitemid 46355938)
24. Ueshima K., Yasuno S., Oba K., Fujimoto A., Mukoyama M., Ogihara T., Saruta T., Nakao K., Impact of left ventricular hypertrophy on the time-course of renal function in hypertensive patients: a subanalysis of the CASE-J trial Circulation Journal 2010 74 10 2132 2138
25. Morsing P., Candesartan: a new-generation angiotensin II AT receptor blocker: pharmacology, antihypertensive efficacy, renal function, and renoprotection Journal of the American Society of Nephrology 1999 10 supplement 11 S248 S254
26. Rincon-Choles H., Kasinath B. S., Gorin Y., Abboud H. E., Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy Kidney International, Supplement 2002 62 82 S8 S11
27. Dounousi E., Papavasiliou E., Makedou A., Ioannou K., Katopodis K. P., Tselepis A., Siamopoulos K. C., Tsakiris D., Oxidative stress is progressively enhanced with advancing stages of CKD American Journal of Kidney Diseases 2006 48 5 752 760 (Pubitemid 44740054)
28. Dou L., Jourde-Chiche N., Faure V., Cerini C., Berland Y., Dignat-George F., Brunet P., The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells Journal of Thrombosis and Haemostasis 2007 5 6 1302 1308 (Pubitemid 46902134)
29. Sela S., Shurtz-Swirski R., Cohen-Mazor M., Mazor R., Chezar J., Shapiro G., Hassan K., Shkolnik G., Geron R., Kristal B., Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease Journal of the American Society of Nephrology 2005 16 8 2431 2438 (Pubitemid 41725061)
30. Welch W. J., Blau J., Xie H., Chabrashvili T., Wilcox C. S., Angiotensin-induced defects in renal oxygenation: role of oxidative stress American Journal of Physiology 2005 288 1 H22 H28
31. Rosenberger C., Khamaisi M., Abassi Z., Shilo V., Weksler-Zangen S., Goldfarb M., Shina A., Zibertrest F., Eckardt K. U., Rosen S., Heyman S. N., Adaptation to hypoxia in the diabetic rat kidney Kidney International 2008 73 1 34 42 (Pubitemid 350273633)
32. Kurtz T. W., Pravenec M., Antidiabetic mechanisms of angiotensin- converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system Journal of Hypertension 2004 22 12 2253 2261 (Pubitemid 39625096)
33. Nagle D. G., Zhou Y. D., Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1) Current Pharmaceutical Design 2006 12 21 2673 2688
34. Wilson W. J., Poellinger L., The dietary flavonoid quercetin modulates HIF-1 activity in endothelial cells Biochemical and Biophysical Research Communications 2002 293 1 446 450 (Pubitemid 34694228)
35. Thomas R., Kim M. H., Epigallocatechin gallate inhibits HIF-1 degradation in prostate cancer cells Biochemical and Biophysical Research Communications 2005 334 2 543 548 (Pubitemid 40982400)
36. Zhang Q., Tang X., Lu Q., Zhang Z., Rao J., Le A. D., Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells Molecular Cancer Therapeutics 2006 5 5 1227 1238 (Pubitemid 43881315)